Company: IMNN
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001493152-25-011598
Chunk: 1

Company: Imunon, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part II, Item 1A
Chunk 1
---
 under the Exchange Act.

On
November 26, 2024, we received a notice from the Staff notifying us that, based upon the closing bid price of our Common Stock, for the
30 consecutive business days prior to the notice, we no longer met the requirement to maintain a minimum closing bid price of $1.00 per
share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we were granted 180 calendar
days, or until May 27, 2025, to regain compliance with the minimum bid price rule. To regain compliance, the closing bid price of our
Common Stock was required to be $1.00 per share or more for a minimum of ten (10) consecutive business days at any time before May 27,
2025. As of May 27, 2025, we were not eligible for an additional 180 calendar day compliance period, as we did not meet the required
Nasdaq initial listing standards, and, on May 28, 2025, we received a delisting notice from Nasdaq. We also received a notice from the
Staff notifying us that, because our stockholders’ equity was below $2.5 million as reported on our Quarterly Report on Form 10-Q
for the quarter ended March 31, 2025, we no longer meet the minimum stockholders’ equity requirement for continued listing on Nasdaq
under Nasdaq Rule 5550(b)(1). On May 29, 2025, we requested a hearing before a Nasdaq Hearing Panel, at which we requested a suspension
of delisting pending our return to compliance. Pursuant to Nasdaq Listing Rule 5815(a)(1)(B), the hearing request stayed the suspension
of trading and delisting of our common stock pending the conclusion of the hearing process. There can be no assurance the Staff or the
Hearings Panel will grant our request for continued listing. We have timely submitted a plan to regain compliance with the foregoing
deficiencies. Although we intend to use all reasonable efforts to achieve compliance with all Nasdaq listing standards, there can be
no assurance that we will be able to regain compliance with the listing standards or that we will otherwise be in compliance with other
applicable Nasdaq listing criteria. Furthermore, Nasdaq may delist our Common Stock for public interest concerns, even if we are able
to regain compliance for continued listing